88_CD Hikma_NNP Pharmaceuticals_NNP PLC_NNP Principal_NN Group_NNP companies_NNS Hikma_NNP Pharmaceuticals_NNP PLC_NNP West-ward_NNP Pharmaceutical_NNP Corporation_NNP Medius_NNP House_NNP LG_NNP 465_CD Industrial_NNP Way_NNP West_NNP 2_CD Sheraton_NNP Street_NNP Eatontown_NNP ,_, New_NNP Jersey_NNP 07724_CD London_NNP W1F_NNP 8BH_NNP USA_NNP UK_NNP Telephone_NNP :_: 1_CD 732 542 1191_CD Telephone_NNP :_: 44 20 7479 4870_CD 4893_CD Facsimile_NNP :_: 1_CD 732 542 6150_CD Facsimile_NNP :_: 44 20 7760 2580_CD Website_NNP :_: www_NN ._.
com_NN Hikma_NNP Farmacutica_NNP S._NNP A._NNP Estrada_NNP Rio_NNP Da_NNP Mo_NNP no._NN ._.
8_CD From_IN 1_CD June_NNP 2006_CD Hikma_NNP Pharmaceuticals_NNP PLCs_NNP 8A_NNP ,_, 8BFervena_NNP address_NN will_MD be_VB :_: 2705-906_CD Terrugem_NNP SNT_NNP 13_CD Hanover_NNP Square_NNP Portugal_NNP London_NNP W1S_NNP 1HW_NNP Telephone_NNP :_: 351 21 9608410_CD UK_NNP Facsimile_NNP :_: 351 21 9615102_CD Telephone_NNP :_: 44 20 7399 2760_CD Facsimile_NNP :_: 44 20 7399 2761_CD Hikma_NNP Pharmaceuticals_NNP Limited_NNP P._NNP O._NNP Box_NNP 182400_CD 11118_CD Amman_NNP Jordan_NNP Telephone_NNP :_: 962_CD 6_CD 5802900_CD Facsimile_NNP :_: 962_CD 6_CD 5827102_CD Advisers_NNPS Auditors_NNS Legal_JJ Advisers_NNP Deloitte_NNP &_CC Touche_NNP LLP_NNP Ashurst_NNP Hill_NNP House_NNP Broadwalk_NNP House_NNP 1_CD Little_NNP New_NNP Street_NNP 5_CD Appold_NNP Street_NNP London_NNP EC4A_NNP 4TR_NNP London_NNP EC2A_NNP 2HA_NNP UK_NNP UK_NNP Brokers_NNS Public_NNP Relations_NNPS Citigroup_NNP Global_NNP Markets_NNP Limited_NNP Brunswick_NNP Group_NNP LLP_NNP Citigroup_NNP Centre_NNP 16_CD Lincolns_NNP Inn_NNP Fields_NNP Canada_NNP Square_NNP London_NNP WC2A_NNP 3ED_NNP London_NNP E14_NNP 5LB_NNP UK_NNP UK_NNP Merrill_NNP Lynch_NNP International_NNP Merrill_NNP Lynch_NNP Financial_NNP Centre_NNP 2_CD King_NNP Edward_NNP Street_NNP London_NNP EC1A_NNP 1HQ_NNP UK_NNP Hikma_NNP Pharmaceuticals_NNP PLC_NNP Contents_VBZ 02_CD Group_NNP at_IN a_DT glance_NN 43_CD Statement_NN of_IN Directors_NNS 04_CD Chairman_NNP and_CC responsibilities_NNS Chief_NNP Executives_NNS review_NN 44_CD Independent_NNP auditors_NNS report_VBP 06_CD Our_PRP$ strengths_NNS 46_CD Consolidated_NNP income_NN statement_NN 14_CD Business_NN and_CC financial_JJ review_NN 47_CD Consolidated_NNP statement_NN of_IN 28_CD Board_NNP of_IN Directors_NNS and_CC recognized_VBN income_NN and_CC expenses_NNS senior_JJ management_NN 48_CD Consolidated_NNP balance_NN sheet_NN 30_CD Report_NNP of_IN the_DT Directors_NNS 49_CD Consolidated_NNP cash_NN flow_NN statement_NN 32_CD Board_NNP report_NN on_IN corporate_JJ 50_CD Notes_NNS to_TO the_DT consolidated_JJ financial_JJ governance_NN statements_NNS 35_CD Audit_NNP Committee_NNP report_NN 81_CD Hikma_NNP Pharmaceuticals_NNP PLC_NNP accounts_VBZ 37_CD Board_NNP report_NN on_IN remuneration_NN 87_CD Shareholder_NN information_NN 88_CD Company_NN information_NN Financial_NNP highlights_VBZ Revenue_NN Operating_NN profit_NN Profit_NN attributable_JJ $_$ million_CD $_$ million_CD to_TO shareholders_NNS $_$ million_CD 23.5_CD %_NN 10.3_CD %_NN 17.1_CD %_NN Diluted_JJ earnings_NNS R&D_NN costs_NNS per_IN share_NN cents_NNS $_$ million_CD 14_CD ._.
1_CD %_NN 70.7_CD %_NN 2004_CD figures_NNS restated_VBN to_TO reflect_VB a_DT change_NN in_IN the_DT presentation_NN of_IN the_DT results_NNS of_IN our_PRP$ associate_NN ,_, IPO_NNP costs_NNS and_CC Medicaid_NNP rebates_NNS ._.
Further_JJ information_NN is_VBZ given_VBN in_IN Designed_JJ and_CC produced_VBN by_IN Radley_NNP Yeldar_NNP ._.
Note_VB 2_CD to_TO the_DT consolidated_JJ financial_JJ statements_NNS ._.
04_CD 04_CD 24.8_CD 212.4_CD 05_CD 28.3_CD 05_CD 262.2_CD 04_CD 04_CD 9.7_CD 62.7_CD 05_CD 05_CD 16.5_CD 69.2_CD 04_CD 37.5_CD 05_CD 43.9_CD Hikma_NNP Pharmaceuticals_NNP PLC_NNP Annual_JJ Report_NNP 2005_CD Hikma_NNP Pharmaceuticals_NNP PLC_NNP Hikma_NNP Pharmaceuticals_NNP PLC_NNP 13_CD Hanover_NNP Square_NNP Annual_JJ Report_NNP 2005_CD London_NNP W1S_NNP 1HW_NNP UK_NNP www_NN ._.
